EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension

Jia-Yong Qiu iD, Shen-Shen Huang iD, Chao Liu, Dong Ding iD, Yan-Hong Xu, Yi-Min Mao iD, Ya-Dong Yuan iD

BMC Cardiovascular Disorders · 2025

DOI: 10.1186/s12872-025-04475-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Cardiovascular Disorders, 2025. Verfasst von Jia-Yong Qiu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei, Chi…. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Pulmonary Arterial Hypertension, DNA-Binding Proteins, Proto-Oncogene Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nature Science Foundation of Henan Province, Key R&D Program Project of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary arterial hypertension (PAH) is a severe and progressive cardiovascular disease. While potential links between clonal hematopoiesis (CH) and cardiovascular diseases have been identified, the causal relationship between CH and PAH remains unclear. This study aims to investigate the causal effect of CH on the risk of PAH using a two-sample Mendelian randomization (MR) approach. METHODS: We utilized genetic variants associated with CH as instrumental variables, identified from two large genome-wide association studies (GWAS) involving 359,088 participants in the discovery cohort and 184,121 participants in the validation cohort, all of European descent. We obtained GWAS summary statistics for PAH. The inverse-variance weighted (IVW) method was employed as the primary analysis, complemented by sensitivity analyses to assess the robustness of our findings. A bidirectional MR analysis was conducted to estimate the causation between CH and PAH. RESULTS: Our results indicate a causal effect of CH on the risk of PAH in the discovery cohort, with TET2 showing an IVW odds ratio (OR) of 1.200 (95% CI: 1.001-1.438, P = 0.049). Sensitivity analysis did not reveal significant pleiotropy or heterogeneity. In the validation cohort, we found that TET2 remains a risk factor for PAH (OR = 2.3E + 08, 95% CI 17.007-3.1E + 15, P = 0.022). Additionally, no causal relationship was found between other CH genes, such as DNMT3A and PAH (P > 0.05). The reverse MR analysis provided no evidence of causal effects of PAH on CH. CONCLUSION: These findings showed that individuals with CH due to TET2 mutations may have a higher risk of developing PAH, suggesting that the CH patients may be tested for TET2 gene mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisPulmonary Arterial HypertensionDNA-Binding ProteinsProto-Oncogene ProteinsPolymorphism, Single NucleotideArterial PressureHumansMendelian Randomization AnalysisGenetic Predisposition to DiseaseDioxygenasesGenome-Wide Association StudyRisk FactorsRisk AssessmentPhenotypeMaleFemaleMiddle AgedDNA Methyltransferase 3A

Stichwörter der Autor:innen

Clonal hematopoiesisInflammationMendelian randomizationPulmonary arterial hypertensionTET2

Substanzen

DioxygenasesTET2 protein, humanDNA-Binding ProteinsProto-Oncogene ProteinsDNMT3A protein, humanDNA Methyltransferase 3A

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, College of Clinical Medicine of Henan, University of Science and Technology, 24 Jinhua Road, Luoyang, China.
  • Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Institute of Clinical Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, National Infrastructures for Translational Medicine, Chinese Academy of Medical Sciences a…
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, College of Clinical Medicine of Henan, University of Science and Technology, 24 Jinhua Road, Luoyang, China. yimin6107@haust.edu.cn.
  • Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei, China. yyd1108@163.com.

ORCID-Profile: Jia-Yong Qiu, Shen-Shen Huang, Dong Ding, Yi-Min Mao, Ya-Dong Yuan

Förderung

  • Nature Science Foundation of Henan Province
  • Key R&D Program Project of Hebei Province

Zitieren

APA

Qiu, J. Y., Huang, S. S., Liu, C., Ding, D., Xu, Y. H., Mao, Y. M., & Yuan, Y. D. (2025). Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-025-04475-4

Vancouver

Qiu JY, Huang SS, Liu C, Ding D, Xu YH, Mao YM, et al. Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension. BMC Cardiovascular Disorders. 2025. doi:10.1186/s12872-025-04475-4

BibTeX
@article{Qiu2025,
  author = {Qiu, Jia-Yong and Huang, Shen-Shen and Liu, Chao and Ding, Dong and Xu, Yan-Hong and Mao, Yi-Min and Yuan, Ya-Dong},
  title = {Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension},
  journal = {BMC Cardiovascular Disorders},
  year = {2025},
  doi = {10.1186/s12872-025-04475-4}
}
Kostenlos starten →